Michigan insurers seek premium hikes as demand for diet drugs soars

Ozempic was originally approved by the FDA to treat people with type 2 diabetes who are at risk of serious health consequences without medication.  In recent months, there has been a spike in demand for Ozempic, or semaglutide, due to its weight-loss benefits, which has led to shortages.  Some doctors prescribe Ozempic off-label to treat obesity.

Michigan health insurers are looking to raise premiums again next year, with rising demand for expensive diabetes and weight-loss drugs like Ozempic and Wegovy contributing to what they see as needed rate hikes. A report from the Michigan Department of Insurance and Financial Services, which reviews and approves insurer rates, shows health insurance companies are … Read more

Patients squeezed into the fight over who gets to bill expensive infusion drugs

A photo of Paula Bruton Shepard receiving an infusion in a hospital.

Health insurers and medical providers are fighting over who should provide high-cost infusion drugs for patients, with the fight over profits now spilling into state homes across the country. The problem is that some insurers are bypassing hospital pharmacies and doctor’s offices and instead shipping more complex drugs through third-party pharmacies. Those pharmacies then ship … Read more

DEA relaxed online prescribing rules during covid. Now he wants to keep them in check.

Kaiser health news

Federal regulators want most patients to see a healthcare provider in person before receiving prescriptions for potentially addictive drugs through telehealth, which hasn’t been required in more than three years. During the covid-19 public health emergency, the Drug Enforcement Administration has allowed doctors and other healthcare professionals to prescribe controlled medications during telehealth appointments without … Read more

Canada’s misguided changes to drug regulation could expedite unproven drugs and divert funds from other healthcare needs

A man in a striped suit and tie seated at a table behind a nameplate with the name of Health Minister Jean-Yves Duclos

Canadian government proposes new Agile licensing framework to accelerate pre-market regulation of pharmaceutical products. While Health Minister Jean-Yves Duclos says this is part of the government’s strategy to give Canadians access to quality, affordable medicines, the policy is likely to cause more harm than good. Adopting Agile Licensing would allow companies to market drugs up … Read more

NASH drugs race to cross finish line – Pharmaceutical Technology

NASH drugs race to cross finish line - Pharmaceutical Technology

Isometric illustration of a liver test. NASH is a condition caused by liver dysfunction. Credit: Mono via Getty Images Following a negative decision by the US Food and Drug Administration (FDA) for Intercept Pharmaceuticals Ocaliva (obeticholic acid), all eyes are now on the next possible drug to lead the race to market for nonalcoholic steatohepatitis … Read more